TAM for Lantheus presentation is 3B Usd by 2029 but I suspect this could grow, just depending on price. It is being used to monitor progress of disease and treatment so definitely not a one price item per person. I would think minimum 2 illuccix per person for those that have in multiple areas. Currently lantheus has 1B USD share and illuccix is 500m USD share. I disregard other competition for now as they have less marrket share. Still plenty of room to get market share for illuccix.
Ann: Telix Submits NDA for New Prostate Cancer Imaging Agent, page-10
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.19 |
Change
0.780(4.24%) |
Mkt cap ! $6.421B | |||
| Open | High | Low | Value | Volume |
| $18.85 | $19.19 | $18.78 | $22.02M | 1.155M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2216 | $19.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.20 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| TLX (ASX) Chart |